Pharma Industrial India Magazine - May-June 2024

PHARMA INDUSTRIALINDIA · MAY-JUN 24 22 INTEEWRSVIEW improved post-operative results. These include a marked re- duction in blood loss and a lower risk of infection, both of which contribute to improved patient outcomes. Patients who under- go robotic surgeries often experience less post-operative pain, enjoy shorter hospital stays, and benefit from a quicker return to their daily activities. The cumulative effect of these advan- tages is a more efficient healthcare system, where patient re - covery is expedited, and the quality of care is elevated. The implementation of Surgical Robotic systems signifies a transformative step forward in surgical practices. It not only re- fines the technical aspects of surgery but also has a profound impact on patient care. As the technology continues to ad- vance, it is anticipated that robotic surgery will become even more integral to modern surgeries, further improving surgical outcomes and patient experiences. Q What are the main challenges in designing surgical ro - botics for multi-specialty applications leveraged by SS Innovations and explain the role of 3D 4K vision technology in robotic surgery systems? Dr. Sudhir Srivastava: The development of surgical robotics tailored to various specialties presents a multitude of challeng- es, the foremost being the assurance that the robotic system is versatile enough to accommodate the diverse array of sur- geries, each with its distinct medical requirements and con - straints. Ensuring the safety, precision, and reliability of these systems is paramount to safeguard patient health and main- tain the confidence of healthcare providers in the technology. Rigorous testing, validation, and adherence to regulatory stan - dards are imperative to address these concerns and mitigate risks associated with complex multi-specialty applications. The integration of cutting-edge technologies such as artificial intelligence (AI) and augmented reality (AR) is essential, yet it is equally important to maintain user-friendly interfaces for surgeons. Moreover, fostering collaboration among engineers, surgeons, and healthcare professionals is critical. Such inter - disciplinary cooperation is instrumental in comprehending the multifaceted needs of the medical community, refining system designs, and catalysing innovation for the application of surgi - cal robots in a variety of specialties. The implementation of 3D 4K vision technology represents a significant advancement for surgical robotic systems, provid - ing surgeons with an immersive, high-resolution view of the operative field enhancing their hand-eye coordination, depth perception, and ability to discern complex anatomical struc - tures with greater accuracy. This technological leap forward enables surgeons to execute procedures with heightened pre- cision, thereby reducing the likelihood of complications and improving patient outcomes. Furthermore, the superior visual - ization offered by 3D 4K technology allows surgeons to identify minute anatomical details with ease, resulting in more precise manoeuvres and superior surgical results. Q Explain the regulatory approval process for medical de - vices in India and how does it compare to the process in the United States and the European Union? Dr. Sudhir Srivastava: The regulatory approval process for medical devices is a critical component of healthcare gover- nance, ensuring the safety and efficacy of devices before they reach the market. In India, this process is administered by the Central Drugs Standard Control Organization (CDSCO), which oversees the evaluation of medical devices based on a com- prehensive set of guidelines to ensure they meet the required safety and performance standards. The timeline for approval in India is variable, and contingent upon the device’s classifi - cation and complexity, and can extend from several months to a few years. In US, the regulatory framework is more stringent, with the Food and Drug Administration (FDA) at the helm of the approv - al process. The FDA’s approach is renowned for its meticulous scrutiny of safety and efficacy data, which encompasses a detailed review of clinical trial results and other pertinent infor- mation. This rigorous process is designed to ensure that only medical devices that meet the highest standards of safety and effectiveness are authorized for use. Hence, the timeline for approval can be protracted, due to the thoroughness of the FDA’s approach to assessment.